We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Product type
Topic
- Advertising (272)
- COVID-19 (163)
- Safety monitoring and information (96)
- Legislation (93)
- Compliance and enforcement (65)
- Manufacturing (52)
- Vaping hub (51)
- Labelling and packaging (35)
- Scheduling (national classification system) (27)
- Import and export (26)
- Medicinal cannabis hub (25)
- Sunscreens (16)
- Shortages and supply disruptions (14)
- Weight loss products (14)
- Committees and advisory bodies (9)
- Cosmetics (5)
- Unique Device Identification (UDI) hub (4)
- Clinical trials (3)
- Fees and payments (2)
- Prescription opioids hub (2)
- Urogynaecological (transvaginal) surgical mesh hub (2)
- Breast implant hub (1)
Search
58 result(s) found, displaying 51 to 58
-
Regulatory decision noticesThe Therapeutic Goods (Permissible Ingredients) Determination has been updated.
-
BlogHow to find information about the inactive ingredients in your medicines.
-
Regulatory decision noticesListed medicine ingredients and requirements have been updated.
-
Regulatory decision noticesThe Permissible Ingredients Determination has been updated.
-
Regulatory decision noticesThe Permissible Ingredients Determination has been updated.
-
Regulatory decision noticesThe Therapeutic Goods (Permissible Indications) Determination has been updated
-
Regulatory decision noticesAn amendment to the Therapeutic Goods (Permissible Ingredients) Determination commenced on 2 September 2019.
-
Regulatory decision noticesThe Therapeutic Goods (Permissible Ingredients) Determination has been updated.